Analystreport

Nabriva Therapeutics plc (NASDAQ: NBRV) had its price target lowered by analysts at Northland Securities from $4.00 to $2.00.

Nabriva Therapeutics plc - Ordinary Shares  (NBRV) 
Last nabriva therapeutics plc - ordinary shares earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.nabriva.com/investor-relations